Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease

Cited by (621)

Items 301–400 of 621

1. El SARS-CoV-2 y otros virus emergentes y su relación con la inocuidad en la cadena alimentaria
   Marcial Ibo Silva-Jaimes · 2020 · Scientia Agropecuaria
2. Liver dysfunction in COVID-19: a useful prognostic marker of severe disease?
   James B. Lok, Markus Gess · 2020 · Frontline Gastroenterology
3. An Adverse Outcomes Approach to Study the Effects of SARS-CoV-2 in 3D Organoid Models
   Amrita Basu, Annapurna Pamreddy, Pragya Singh, Kumar Sharma · 2021 · Journal of Molecular Biology
4. Characteristics of hospitalised COVID‐19 patients and parameters associated with severe pneumonia
   Onur Turan, Arzu Mirici, Serap Akçalı Duru, Pakize Ayşe Turan, Özgür Batum, Aysun Şengül, Zuhal Ekici, Nalan Işık Kabakoğlu, Nalan Ogan, Şerife Torun et al. · 2021 · International Journal of Clinical Practice
5. Therapeutic role of vitamin D in COVID-19 patients
   Muhammad Imran, Ramna Zia, Maryam Ali, Saima Sadaf, Kiran Iqbal, Asad Ali, Usama Iqbal, Sana Muhammad Din, Jawaria Shahid, Ahsan Ali et al. · 2024 · Clinical Nutrition Open Science
6. Diagnosis and treatment of acute coronary syndrome during the novel coronavirus infection COVID-19 pandemic
   Намитоков Алим Муратович, O. P. Ishevskaia, В. И. Фетисова, Elena D. Kosmacheva, Vladimir Alekseyevich Porkhanov · 2020 · Russian Journal of Cardiology
7. Emerging mechanisms for the new Coronavirus-related myocardial injury and ischemia, a review of the literature
   Mohammad Mostafa Ansari Ramandi · 2020 · The Anatolian Journal of Cardiology
8. H2S protects from oxidative stress-driven ACE2 expression and cardiac aging
   Kalem Barrow, Yuehong Wang, Ruihuan Yu, Jiechun Zhu, Guangdong Yang · 2022 · Molecular and Cellular Biochemistry
9. Heart rate variability as an indicator of COVID-19 induced myocardial injury: a retrospective cohort study
   Hani I. Taman, Nabil A. Mageed, Mohamed M. Elmorsy, Sherif I. Elfayoumy, Mostafa Sayed Ahmed Mohammed Elawady, Ahmed M. Farid, Mohamed Abdelmonem, Ibrahim Abdelbaser · 2023 · BMC Anesthesiology
10. The Multi-faceted Effects of COVID-19 on Female Reproductive Health: An Updated Narrative Review
    Adnan A.H. Albdairi, Hayder Abdul-Amir Makki Al-Hindy, Osama Shawki, Sallama Hamid Alkhudair, Nadia Mudher Al-Hilli, Batool Abdulwahid Alkhalidi, Hanan K Alkadhim, Ashwaq A Shweliyya · 2024 · Cureus
11. Decreased Renal Function Induced by High-Fat Diet in Wistar Rat: The Role of Plasma Angiotensin Converting Enzyme 2 (ACE2)
    Ridwan Ridwan, Rosdiana Natzir, Haerani Rasyid, Ilhamjaya Patellongi, Mochammad Hatta, Elmiana Bongga Linggi, Agussalim Bukhari, Uleng Bahrun · 2019 · Biomedical & Pharmacology Journal
12. Comment on ‘Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?’
    Erkan Cüre, Medine Cumhur Cüre · 2020 · Journal of Hypertension
13. Increased susceptibility of SARS-CoV2 infection on oral cancer patients; cause and effects: An hypothesis
    Anshika Chauhan, Sushmita Ghoshal, Arnab Pal · 2020 · Medical Hypotheses
14. Molecular Basis for Pathogenicity of Human Coronaviruses
    Fatemeh Pourrajab, Mohamad Reza Zare‐Khormizi, Mohammad Hasan Sheikhha · 2020 · Infection and Drug Resistance
15. SARS-CoV-2/human interactome reveals ACE2 locus crosstalk with the immune regulatory network in the host
    Christy Lite, Shiek S. S. J. Ahmed, Melita Juliet, Allen J. Freddy · 2021 · Pathogens and Disease
16. SARS-CoV-2, Endothelial Dysfunction, and the Renin-Angiotensin System (RAS): A Potentially Dangerous Triad for the Development of Pre-Eclampsia
    Barbara Illi, Barbara Vasapollo, Herbert Carmelo Carlo Valensise, Pierangela Totta · 2021 · Reproductive Medicine
17. Understanding the immunological aspects of SARS-CoV-2 causing COVID-19 pandemic: A therapeutic approach
    Ananya Das, Sraddhya Roy, Snehasikta Swarnakar, Nabanita Chatterjee · 2021 · Clinical Immunology
18. Demographic, Clinical, and Co-Morbidity Characteristics of COVID-19 Patients: A Retrospective Cohort from a Tertiary Hospital in Kenya
    Reena Shah, Jasmit Shah, Nancy Kunyiha, Sayed K. Ali, Shahin Sayed, Salim Surani, Mansoor Noorali Saleh · 2022 · International Journal of General Medicine
19. COVID-19 and the Microbiome: The Gut-Lung Connection
    Femke J. Aan, Natalija Glibetić, Vanessa Montoya‐Uribe, Michelle L. Matter · 2021 · Elsevier eBooks
20. The modelling of COVID19 pathways sheds light on mechanisms, opportunities and on controversial interpretations of medical treatments. v2
    Maria Luisa Chiusano · 2020 · arXiv (Cornell University)
21. Efficient inhibition of SARS-CoV-2 strains by a novel ACE2-IgG4-Fc fusion protein with a stabilized hinge region
    Hristo L. Svilenov, Julia Sacherl, A. Reiter, Lisa S. Wolff, Cho-Chin Chen, Marcel Stern, Frank‐Peter Wachs, Nicole Simonavicius, Susanne D. Pippig, Florian Wolschin et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
22. COVID-19 Vaccination Might Induce Reversible Cerebral Vasoconstriction Syndrome Attacks: A Case Report
    Anne Lund, Mohammad Al‐Mahdi Al‐Karagholi · 2022 · Vaccines
23. Molecular dynamics simulations of the SARS-CoV-2 Spike protein and variants of concern: structural evidence for convergent adaptive evolution
    Daniel Ferreira de Lima Neto, Vagner Fonseca, Ronaldo de Jesus, Leonardo Hermes Dutra, Layssa Miranda de Oliveria Portela, Carla Simone Moreira de Freitas, Eduardo Fillizola, Breno Soares, André Luiz de Abreu, Sandeep Twiari et al. · 2022 · Journal of Biomolecular Structure and Dynamics
24. More than a key—the pathological roles of SARS-CoV-2 spike protein in COVID-19 related cardiac injury
    Zhiqiang Lin · 2023 · Sports Medicine and Health Science
25. Effective Use of Angiotensin II in Coronavirus Disease 19–Associated Mixed Shock State: A Case Report
    Kevin A Bobeck, Arthur W. Holtzclaw, Tara E. Brown, Paul A. Clark · 2020 · A&A Practice
26. Angiotensin-converting enzyme 2 receptors, chronic liver diseases, common medications, and clinical outcomes in coronavirus disease 2019 patients
    Wattana Leowattana · 2021 · World Journal of Virology
27. Renal biomarkers of acute kidney injury in response to increasing intermittent hypoxia episodes in the neonatal rat
    Anano Zangaladze, Charles L. Cai, Matthew Marcelino, Jacob V. Aranda, Kay D A Beharry · 2021 · BMC Nephrology
28. RACCOVID-19: primer Registro Argentino de Complicaciones Cardiovasculares en pacientes con COVID-19
    Lucia Raquel Kazelián, Gerardo Zapata, Stella M. Pereiro, Mariano Maydana, Adrián J. Lescano, Alberto J. Lorenzatti, Jose Luis Navarro Estrada · 2021 · Revista Argentina de Cardiología
29. Evaluation of Simple Lateral Flow Immunoassays for Detection of SARS-CoV-2 Neutralizing Antibodies
    Olaf Nickel, Alexandra Rockstroh, Stephan Borte, Johannes Wolf · 2022 · Vaccines
30. Risk factors for COVID-19 infection and disease severity in Nigeria: a case-control study
    Rowland Utulu, IkeOluwapo O. Ajayi, Segun Bello, Muhammad Shakir Balogun, Ugochukwu Chinyem Madubueze, Idayat Temitope Adeyemi, Olajumoke Temitope Omoju, Azuka Stephen Adeke, Adetunji Olusesan Adenekan, Osarhiemen Iyare · 2022 · Pan African Medical Journal
31. COVID-19 associated thyroid dysfunction and other comorbidities and its management using phytochemical-based therapeutics: a natural way
    Arpana Parihar, Shivani Malviya, Raju Khan, Ajeet Kumar Kaushik, Ebrahim Mostafavi · 2023 · Bioscience Reports
32. COVID’s Razor: RAS Imbalance, the Common Denominator Across Disparate, Unexpected Aspects of COVID-19
    Maureen E. Czick, Christine Shapter, Robert Shapter · 2020 · Diabetes Metabolic Syndrome and Obesity
33. A Novel Coronavirus Disease (COVID-19): a Review of Host Cell Signaling Pathways.
    Hadiseh Mohammadpour, Ali Ziai, Makan Sadr, Mitra Sadat Rezaei, Majid Marjani, Payam Tabarsi · 2020 · PubMed Central
34. Algal proteins and bioactive peptides: Sustainable nutrition for human health
    Tianzeng Meng, Jiahui Wen, Hanqi Liu, Yuxin Guo, Aijun Tong, Yaoyao Chu, Bin Du, Xinxin He, Chao Zhao · 2025 · International Journal of Biological Macromolecules
35. Whey-Derived Peptides at the Heart of the COVID-19 Pandemic
    Yara Chamata, Kim G. Jackson, Kimberly A. Watson, Paula Jauregi · 2021 · International Journal of Molecular Sciences
36. Clinical characteristics and mortality associated with COVID-19 in islamic hospital of Jemursari, Surabaya, Indonesia: A hospital-based retrospective cohort study
    Evi Awwaliyah, Hotimah, Michio Shimabukuro · 2022 · Bali Medical Journal
37. Cardiovascular risk in COVID-19 infection.
    Valter Lubrano, Silvana Balzan · 2020 · PubMed Central
38. Vitamin D in the time of the coronavirus (COVID-19) pandemic – a clinical review from a public health and public mental health perspective
    Ursula Werneke, Fiona Gaughran, David M. Taylor · 2021 · Therapeutic Advances in Psychopharmacology
39. Exacerbation of COVID 19 in Hypertensive Patients ( A review)
    Noor Hatef Naser, Ammar Abdul Aziz Alibeg · 2021 · Iraqi Journal of Pharmaceutical Sciences
40. The dynamic nature of the coronavirus receptor, angiotensin-converting enzyme 2 (ACE2) in differentiating airway epithelia
    Vincent J. Manna, Ha-Na Choi, Shawna M. Rotoli, Salvatore J. Caradonna · 2022 · BBA Advances
41. Unravelling the Mechanistic Role of ACE2 and TMPRSS2 in Hypertension: A Risk Factor for COVID-19
    Nalini Govender, Olive Pearl Khaliq, Jagidesa Moodley, Thajasvarie Naicker · 2022 · Current Hypertension Reviews
42. Respiratory issues in patients with multiple sclerosis as a risk factor during SARS-CoV-2 infection: a potential role for exercise
    Omid Razi, Ana Maria Teixeira, Bakhtyar Tartibian, Nastaran Zamani, Beat Knechtle · 2022 · Molecular and Cellular Biochemistry
43. Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19
    Agustı́n Valenzuela-Fernández, Romina Cabrera-Rodríguez, Laura Ciuffreda, Silvia Pérez-Yanes, Judith Estévez‐Herrera, Rafaela González‐Montelongo, Julia Alcoba-Flórez, Rodrigo Trujillo‐González, Diego García-Martínez de Artola, Helena Gil-Campesino et al. · 2022 · Frontiers in Bioengineering and Biotechnology
44. Role of ACE2 Gene Expression in Renin Angiotensin System and Its Importance in Covid-19: In Silico Approach
    Sevgi Kalkanlı Taş, Duygu Kırkık, Mehmet Emirhan Işık, Nevin Kalkanli, Aylin Seher Uzunoğlu, Merve Saide Uzunoğlu, Derya Altunkanat, Jalal Mohammed Mohammed Alragabi, Alpaslan Tanoğlu · 2020 · Brazilian Archives of Biology and Technology
45. Management of Coronavirus Disease 2019 (COVID‐19) Pandemic: From Diagnosis to Treatment Strategies
    Zhina Hadisi, Tavia Walsh, Seyed Mohammad Hossein Dabiri, Amir Seyfoori, David Hamdi, Bahram Mirani, Erik Pagan, Armando Jardim, Mohsen Akbari · 2020 · Advanced Therapeutics
46. The Novel Aspirin as Breakthrough Drug for COVID-19: A Narrative Review
    Bamidele Johnson Alegbeleye, Oke-Oghene Philomena Akpoveso, Adewale James Alegbeleye, Rana Kadhim Mohammed, Eduardo Esteban Zubero · 2020 · Iberoamerican Journal of Medicine
47. Potential Application of Bionanoparticles to Treat Severe Acute Respiratory Syndrome Coronavirus-2 Infection
    Sujit Kumar Debnath, Rohit Srivastava · 2022 · Frontiers in Nanotechnology
48. Acute kidney injury is associated with severe and fatal outcomes in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies
    Mohammad Parohan, Sajad Yaghoubi, Mahmoud Djalali, Asal Seraji, Mohammad Hassan Javanbakht, Zahra Sadat Mousavi · 2020 · medRxiv
49. Preventive Medicinal Plants and their Phytoconstituents against SARS-CoV-2/COVID-19
    Neelesh Kumar Nema, Ghouse Modin Nabeesab Mamdapur, Smitha Sarojam, Swapnil Devidas Khamborkar, Linson Cheruveettil Sajan, Sachithra Sabu, Baby Kumaranthara Chacko, Viju Jacob · 2021 · Pharmacognosy Research
50. Repurposing of RAS-Pathway Mediated Drugs for Intestinal Inflammation Related Diseases for Treating SARS-CoV-2 Infection
    S Anupriya, Raghavendra Goud Vaggu, Ramakrushna Swain, Srinivas Patnaik · 2023 · Current Microbiology
51. A potential hypothesis for 2019-nCoV infection therapy through delivery of recombinant ACE2 by red blood cell-hitchhiking
    Zahra Sadat Aghili, Seyed Abbas Mirzaei, Mehdi Banitalebi-Dehkordi · 2020 · Journal of Biological Research - Thessaloniki
52. SARS-CoV-2 Is More Efficient than HCoV-NL63 in Infecting a Small Subpopulation of ACE2+ Human Respiratory Epithelial Cells
    Gino Castillo, Rahul K. Nelli, Kruttika S. Phadke, Marlene Bravo‐Parra, Juan Carlos Mora-Díaz, Bryan H. Bellaire, Luis Gabriel Gimenez-Lirola · 2023 · Viruses
53. COVID-19 and cardiovascular complications: updates of emergency medicine
    Jianli Zhao, Yaoli Xie, Zhijun Meng, Caihong Liu, Yalin Wu, Fujie Zhao, Xinliang Ma, Theodore A. Christopher, Bernard Lopez, Yajing Wang · 2023 · Emergency and Critical Care Medicine
54. The Intersection Between COVID-19, Cardiovascular Disease, and Diet: a Review
    Tanusha S. Tholla, Caleigh M Sawicki, Shilpa N Bhupathiraju · 2023 · Current Atherosclerosis Reports
55. Infusion of HLA-matched and static magnetic field-exposed allogenic lymphocytes treating lymphocytopenia and cytokine storm syndrome: A treatment proposal for COVID-19 patients
    Cristian Vergallo · 2020 · Electromagnetic Biology and Medicine
56. COVID-19: Case fatality and ACE2 inhibitors treatment concerns in patients with comorbidities.
    Rokhsareh Aghili, Maryam Honardoost, Mohammad E. Khamseh · 2020 · Europe PMC (PubMed Central)
57. Exploring G protein-coupled receptors and yeast surface display strategies for viral detection in baker's yeast: SARS-CoV-2 as a case study
    Carla Maneira, Pamela Magalí Bermejo, Gonçalo Amarante Guimarães Pereira, Fellipe da Silveira Bezerra de Mello · 2021 · FEMS Yeast Research
58. The COVID-19 Patient in the Surgical Intensive Care Unit
    Ian Monroe, Matthew A. Dale, Michael J. Schwabe, Rachel Schenkel, Paul J. Schenarts · 2021 · Surgical Clinics of North America
59. COVID-19: Case fatality and ACE2 inhibitors treatment concerns in patients with comorbidities
    Rokhsareh Aghili, Maryam Honardoost, Mohammad E. Khamseh · 2020 · Medical Journal of the Islamic Republic of Iran
60. Relation of ACE2 with co-morbidity factors in SARS-CoV-2 pathogenicity
    Dipannita Santra, Amrita Banerjee, Subrata Kr. De, Hrudayanath Thatoi, Smarajit Maiti · 2023 · Comparative Clinical Pathology
61. What Is the Role of Angiotensin-Converting Enzyme 2 (ACE2) in COVID-19 Infection in Hypertensive Patients With Diabetes?
    Thadathilankal-Jess John, K John · 2020 · Canadian Journal of Cardiology
62. Therapeutic targets of natural products for the management of cardiovascular symptoms of coronavirus disease 2019
    Pardis Mohammadi Pour, Mohammad Hosein Farzaei, Ebrahim Soleiman Dehkordi, Anupam Bishayee, Sedigheh Asgary · 2021 · Phytotherapy Research
63. Acute Kidney Injury Associated with Severe SARS-CoV-2 Infection: Risk Factors for Morbidity and Mortality and a Potential Benefit of Combined Therapy with Tocilizumab and Corticosteroids
    Jose I. Iglesias, Andrew V. Vassallo, Justin Ilagan, Song Peng Ang, Ndausung Udongwo, Anton Mararenko, Abbas Alshami, Dylon Patel, Yasmine Elbaga, Jerrold S. Levine · 2023 · Biomedicines
64. The Association Between Genetic Variants in ACE1and ACE2 Genes with Susceptibility to COVID-19 Infection
    H. Abbaszadeh, Hamid Kabiri-rad, Fariba Mohammadi, Soheila Zangoie, Mahdieh Rajabi-Moghaddam, Shokouh Ghafari, Masood Ziaee, D. Javanmard, Ebrahim Miri-Moghaddam · 2024 · Biochemical Genetics
65. Microvascular Changes during Viral Infections: A Systematic Review of Studies Using Retinal Vessel Diameter Assessments
    Adam Saloň, Patrick De Boever, Nandu Goswami · 2024 · Biomedicines
66. Fullerenol C60(OH)40 Nanoparticles and Ectoine Protect Human Nasal Epithelial Cells Against the Cytokine Storm After Addition of the Full-Length Spike Protein from SARS-CoV-2
    Malwina Sosnowska, Mateusz Wierzbicki, Barbara Nasiłowska, Totka Bakalová, Klara Zglińska, Barbara Strojny, Ewa Sawosz, Marta Kutwin · 2024 · International Journal of Nanomedicine
67. Possible benefits of exogenous melatonin for individuals on dialysis: a narrative review on potential mechanisms and clinical implications
    Seyed Majid Mousavi Movahed · 2021 · Naunyn-Schmiedeberg s Archives of Pharmacology
68. Clinical Signs, Laboratory Diagnosis and Treatments Involved in Corona Viruses-19
    Israa Burhan Raoof, Zahraa Ahmed Okhti, Mayssaa E. Abdalah · 2022 · Al Mustansiriyah Journal of Pharmaceutical Sciences
69. Bioactive compounds as potential angiotensin-converting enzyme II inhibitors against COVID-19: a scoping review
    Pedro Henrique de Matos, Thalita Prates da Silva, Amanda Benites Mansano, Naiara Cássia Gancedo, Fernanda S. Tonin, Fernando Castilho Pelloso, Marcus Vinícius Petruco, Eduardo Borges de Melo, Fernando Fernández-Llimós, Andréia Cristina Conegero Sanches et al. · 2022 · Inflammation Research
70. Association between hypertension and clinical outcomes in COVID-19 patients: a case-controlled study
    Fatemeh Aslanbeigi, Habiballah Rahimi, Adeleh Malekipour, Hamed Pahlevani, Maedeh Najafizadeh, Hassan Ehteram, Fatemeh Izadpanah, Hamed Haddad Kashani · 2023 · Annals of Medicine and Surgery
71. Comparative transcriptome analysis of SARS-CoV-2, SARS-CoV, MERS-CoV, and HCoV-229E identifying potential IFN/ISGs targets for inhibiting virus replication
    Yuzhuang Liu, Tianyi Lu, Cuidan Li, Xiaotong Wang, Fei Chen, Liya Yue, Chunlai Jiang · 2023 · Frontiers in Medicine
72. Does the direct renin inhibitor have a role to play in attenuating severity of the outbreak coronavirus disease 2019 (COVID-19)?
    Cheng-Wei Lin, Yu‐Yao Huang · 2020 · Therapeutic Advances in Endocrinology and Metabolism
73. Comparative molecular docking analysis of the SARS CoV-2 Spike glycoprotein with the human ACE-2 receptors and thrombin
    Piyush Bhanu · 2020 · Bioinformation
74. COVID-19: A Concern for Cardiovascular Disease Patients
    Shruti Sharma · 2020 · Cardiovascular Toxicology
75. Immunosuppressed Patients and the Risk of COVID-19: A Narrative Review
    Fabrício Tavares Mendonça, Fabrício Tavares Mendonça · 2020 · Clinical Oncology and Research
76. Cardiology and COVID-19: do We have Sufficient information?
    Nikita Garg, Brendan McClafferty, Devyani Ramgobin, Reshma Reddy Golamari, Rahul Jain, Rohit Jain · 2020 · Future Cardiology
77. Factors for COVID-19 Infection that Govern the Severity of Illness
    Bidisha Ghosh, Soumyadev Sarkar, Nayim Sepay, Kaustuv Das, Sukhen Das, Sujata Ghosh Dastidar · 2021 · SciMedicine Journal
78. Cautions on the laboratory indicators of COVID‐19 patients on and during admission
    Haiting Liu, Xueling Shang, Sai Chen, Tie Li, Junhua Zhang · 2021 · Journal of Clinical Laboratory Analysis
79. Pediatrics and COVID-19
    Tuna Toptan, Sandra Ciesek, Sebastian Hoehl · 2021 · Advances in experimental medicine and biology
80. Cardiovascular diseases in combination with SARS-CoV-2 viral infection: cours and forecast
    Gushchina O.I., Н. Г. Ложкина · 2021 · Ateroscleroz
81. Mechanical dependency of the SARS-CoV-2 virus and the renin-angiotensin-aldosterone (RAAS) axis: a possible new threat
    Rohit Sen, Devashish Sengupta, Avinaba Mukherjee · 2021 · Environmental Science and Pollution Research
82. SARS-CoV-2 Infections, Impaired Tissue, and Metabolic Health: Pathophysiology and Potential Therapeutics
    Shailendra Pratap Singh, Abhinav Kanwal, Salomon Amar, Aayushi Bhatnagar, Sujeet Kumar Singh, Sanjib K. Patra, Navjot Kanwar, Ranata Manna · 2022 · Mini-Reviews in Medicinal Chemistry
83. Distribution of Coronavirus Receptors in the Swine Respiratory and Intestinal Tract
    Rahul K. Nelli, James A. Roth, Luis Gabriel Gimenez-Lirola · 2022 · Veterinary Sciences
84. Impact of Glycemic Control in Diabetes Mellitus on Management of COVID-19 Infection
    Sudhir Bhandari, Govind Rankawat, Ajeet Singh, Vishal Anand Gupta, Shivankan Kakkar · 2021 · Journal of Diabetology
85. Tailoring glucocorticoids in patients with severe COVID-19: a narrative review
    Ming-Hao Luo, Yi-Qi Qian, Dan-Lei Huang, Jing‐chao Luo, Ying Su, Huan Wang, Shen-Ji Yu, Kai Liu, Guo-Wei Tu, Zhe Luo · 2021 · Annals of Translational Medicine
86. The Pathophysiology of Virulence of the COVID-19
    Joseph De Soto, Shazia Tabassum Hakim, Frederick Boyd · 2020 · Preprints.org
87. Balancing Regeneration and Resistance: Targeting DCLK1 to Mitigate Gastrointestinal Radiation Injury and Oncogenesis
    Landon L. Moore, Jerry Jeff Jaboin, Milton L. Brown, Courtney W. Houchen · 2025 · Cancers
88. Coronavirus Disease in Cardiovascular Patients: Clinical Characteristics and Final Prognosis
    Amirhossein Yazdi, Maryam Alvandi, Zahra Shaghaghi, Seyyed Hamid Hashemi, Seyed Omid Inanloo, SayedPayam Hashemi, Tayeb Mohammadi, Surur Akbari · 2023 · Avicenna Journal of Clinical Microbiology and Infection
89. Fat-Soluble Vitamins
    Darshan Malik, Nandita Narayanasamy, V A Pratyusha, Jayita Thakur, Nimisha Sinha · 2023 · Springer eBooks
90. Optimized SARS-CoV-2 spike protein detection via coupling coefficient-driven fast fourier transform analysis in a peptide-functionalized fiber optic biosensor
    Oskar Arrizabalaga, Alain Castaño Andres, Jose Luis Zugaza, Joseba Zubía · 2025 · Sensors and Actuators B Chemical
91. Clinical cardiac manifestations in patients with coronavirus disease 2019 (COVID-19)
    Hafizha Herman, Putrika Prastuti Ratna Gharini, Lucia Kris Dinarti · 2020 · Journal of the Medical Sciences (Berkala Ilmu Kedokteran)
92. Target SARS-CoV-2: theoretical exploration on clinical suitability of certain drugs
    S. M. Abdul Nayeem, Ershad Mohammed Sohail, N. V. Srihari, P. Indira, Munnangi Srinivasa Reddy · 2021 · Journal of Biomolecular Structure and Dynamics
93. Disparities in PM2.5 exposure and population density influence SARS-CoV-2 transmission among racial and ethnic minorities
    Payton Beeler, Rajan K. Chakrabarty · 2021 · Environmental Research Letters
94. The Importance of Natural ACE2 Inhibitor: Potency of Porang (Amorphophallus muelleri) Glucomannan as Anti-SARS-Cov-2
    Amira Hasnanuha Ulayya, Nashi Widodo, Ahmad Zaki Mubarok, Simon Bambang Widjanarko, Marlita Marlita · 2021 · Electronic Journal of General Medicine
95. Angiotensin 1-7 and its analogue decrease blood pressure but aggravate renal damage in preeclamptic mice
    Yuan Liu, Ruonan Zhai, Jiahao Tong, Ying Yu, Lin Yang, Yong Gu, Jianying Niu · 2022 · EXPERIMENTAL ANIMALS
96. Is chymase 1 a therapeutic target in cardiovascular disease?
    Carlos Maria Ferrario, Sarfaraz Ahmad, Robert Charles Speth, Louis J. Dell’Italia · 2023 · Expert Opinion on Therapeutic Targets
97. Cardiovascular and Venous Thromboembolic Events After Hospital Discharge for COVID-19: A Prospective Single Center Study
    Simon Soudet, Damien Basille, Hortense Carette, M. Mercier, Claire Andréjak, Marie‐Antoinette Sevestre · 2023 · Angiology
98. Clinical implications of a mechanistic link connecting SARS-Cov-2, diabetes mellitus, Zinc in COVID-19 pathophysiology, and the prophylactics in the treatment of SARS-CoV-2
    Deeptimayee Rout, Atish Kumar Sahoo · 2023 · European Journal of Medicinal Chemistry Reports
99. Platforms for Personalized Polytherapeutics Discovery in COVID-19
    Christopher E. Hopkins, Chidinma L. Onweni, Victoria Zambito, DeLisa Fairweather, Kathryn McCormick, Hideki Ebihara, Thomas R. Caulfield, Yu Shrike Zhang, William David Freeman · 2021 · Journal of Molecular Biology
100. Risk of Covid-19-Related Hospitalization and More Severe Outcomes in Medicare Beneficiaries Treated with Renin-Angiotensin-Aldosterone System Inhibitors for Hypertension
     David J. Graham, Héctor S. Izurieta, Stella G. Muthuri, Di Zhang, Alexander T. Sandhu, Yun Lu, Yueqin Zhao, Yuhui Feng, Efe Eworuke, Hai Lyu et al. · 2021 · Journal of General Internal Medicine